Stephen W. Wright
DuPont
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen W. Wright.
Tetrahedron Letters | 1992
Stephen W. Wright; Matthew Mark Abelman; Lori L. Bostrom; Ronald L. Corbett
Abstract A new methodology is described for the synthesis of benzisothiazolones from benzylsulfinyl or t-buthylsulfinyl substituted carboxamides that provides a mild alternative to conventional cyclization methods that employ halogens.
Tetrahedron Letters | 1993
Stephen W. Wright; Ronald L. Corbett
Abstract A new methodology is described for the synthesis of 3-hydroxybenzothiophenes, 3-hydroxypyridothiophenes, and the corresponding selenophene analogs by the base promoted cyclization of corresponding 2-(benzylthio)arenecarboxanilides. The starting materials are readily prepared using directed metalation of the corresponding arenecarboxanilides.
Bioorganic & Medicinal Chemistry | 1995
Stephen W. Wright; Joseph J. Petraitis; Douglas G. Batt; Ronald L. Corbett; Susan V. Di Meo; Bruce Freimark; John V. Giannaras; Michael J. Orwat; Donald J. P. Pinto; Michael A. Pratta; Susan R. Sherk; Herman F. Stampfli; Jean M. Williams; Ronald L. Magolda; Elizabeth C. Arner
A series of 2-(arylmethyl)pyridoisothiazolones is reported that inhibit the IL-1 beta induced breakdown of bovine nasal septum cartilage in an organ culture assay. The synthesis and preliminary SAR of these compounds are described. These compounds represent a novel, non-peptide lead series approach to the mediation of the chronic cartilage breakdown associated with arthritic disease. These compounds are relatively resistant to reductive metabolism by liver microsomal preparations and appear to inhibit cartilage breakdown by interfering with the proteolytic activation of matrix metalloproteinases.
Bioorganic & Medicinal Chemistry | 1996
Stephen W. Wright; Joseph J. Petraitis; Bruce Freimark; John V. Giannaras; Michael A. Pratta; Susan R. Sherk; Jean M. Williams; Ronald L. Magolda; Elizabeth C. Arner
A series of 2,5-diarylisothiazolones is reported that inhibit the IL-1 beta-induced breakdown of bovine nasal septum cartilage in an organ culture assay. The synthesis and preliminary SAR of these compounds are described. These compounds represent a novel, nonpeptide lead series approach to the mediation of the chronic cartilage breakdown associated with arthritic disease. These compounds are relatively resistant to reductive metabolism by liver microsomal preparations and appear to inhibit cartilage breakdown by interfering with the proteolytic activation of matrix metalloproteinases.
Bioorganic & Medicinal Chemistry Letters | 1993
Stephen W. Wright; Joseph J. Petraitis; Matthew Mark Abelman; Lori L. Bostrom; Ronald L. Corbett; Alicia M. Green; Rachel M. Kindt; Susan R. Sherk; Ronald L. Magolda
Abstract Isothiazolones and isoselenazolones have been found to inhibit IL-1β induced breakdown of bovine nasal cartilage in an organ culture assay. The synthesis and preliminary SAR of these compounds are described. These compounds represent a novel, non-peptide lead series approach to the mediation of the chronic cartilage breakdown associated with arthritic disease.
Bioorganic & Medicinal Chemistry Letters | 1992
Stephen W. Wright; Mark J. Nelson
Abstract A set of epoxide and episulfide substrate mimics were synthesized as inhibitors of soybean lipoxygenase. Enzyme inhibition was observed exclusively with the 12,13-episulfides (1a and 4a), with a high degree of regio- and chemoselectivity. Inhibition by 1a was shown to occur with reduction of the enzyme active site iron from the catalytically active Fe(III) to the inactive Fe(II).
Bioorganic & Medicinal Chemistry Letters | 1992
Stephen W. Wright; Donald J. P. Pinto; Susan R. Sherk; Alicia M. Green; Ronald L. Magolda
Abstract Vinylogous hydroxamic acids were prepared as inhibitors of 5-lipoxygenase. The synthesis and preliminary SAR of these relatively unexplored compounds are described. These compounds are potent 5-lipoxygenase inhibitors which do not inhibit other enzymes of the arachidonic acid cascade.
Journal of Medicinal Chemistry | 1992
Stephen W. Wright; Richard R. Harris; Janet S. Kerr; Alicia M. Green; Donald J. P. Pinto; Elaine M. Bruin; Robert J. Collins; Roberta L. Dorow; Lisa R. Mantegna
Archive | 1990
Ronald L. Magolda; Stephen W. Wright
Archive | 1991
Douglas G. Batt; Stephen W. Wright